Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,301 | 344 | 99.6% |
| Education | $22.25 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $995.81 | 52 | $0 (2023) |
| PFIZER INC. | $823.39 | 58 | $0 (2024) |
| Amgen Inc. | $442.11 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $366.01 | 46 | $0 (2019) |
| GlaxoSmithKline, LLC. | $286.12 | 17 | $0 (2022) |
| Novo Nordisk Inc | $221.08 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $219.74 | 13 | $0 (2024) |
| ABBVIE INC. | $180.50 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $177.65 | 12 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $171.32 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $224.36 | 11 | ABBVIE INC. ($61.47) |
| 2023 | $284.84 | 14 | Celgene Corporation ($80.97) |
| 2022 | $234.43 | 13 | ABBVIE INC. ($67.03) |
| 2021 | $53.69 | 3 | AbbVie Inc. ($23.50) |
| 2020 | $391.07 | 22 | AstraZeneca Pharmaceuticals LP ($114.48) |
| 2019 | $1,438 | 97 | AstraZeneca Pharmaceuticals LP ($296.63) |
| 2018 | $1,547 | 105 | AstraZeneca Pharmaceuticals LP ($299.25) |
| 2017 | $1,150 | 83 | AstraZeneca Pharmaceuticals LP ($244.84) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Oncology | ||||||
| 07/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Obesity | ||||||
| 03/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Oncology | ||||||
| 03/15/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Inflammation | ||||||
| 02/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Obesity | ||||||
| 01/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Cardiovascular | ||||||
| 11/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/03/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/22/2023 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Cardiovascular | ||||||
| 09/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/17/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Oncology | ||||||
| 07/14/2023 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.32 | General |
| Category: Cardiovascular | ||||||
| 06/23/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.50 | General |
| 06/02/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/27/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/20/2023 | Celgene Corporation | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: Cardiovascular | ||||||
| 01/18/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.75 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 749 | 925 | $179,750 | $36,080 |
| 2022 | 13 | 917 | 1,126 | $202,822 | $39,741 |
| 2021 | 16 | 1,476 | 1,738 | $213,590 | $60,803 |
| 2020 | 16 | 719 | 1,059 | $202,404 | $56,219 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 155 | 261 | $70,458 | $11,795 | 16.7% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 298 | 298 | $11,920 | $11,574 | 97.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 141 | 246 | $44,496 | $10,426 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 138 | 138 | $45,098 | $7,421 | 16.5% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 297 | 302 | $10,624 | $5,881 | 55.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 62 | 62 | $4,799 | $4,042 | 84.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 38 | 76 | $8,409 | $3,022 | 35.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 101 | 101 | $4,579 | $1,821 | 39.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 97 | 97 | $2,438 | $1,739 | 71.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 64 | 65 | $4,083 | $1,075 | 26.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 11 | $2,825 | $799.24 | 28.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 16 | $1,680 | $447.38 | 26.6% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 16 | 17 | $900.00 | $443.59 | 49.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $777.00 | $214.88 | 27.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 17 | 21 | $156.00 | $73.08 | 46.8% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 14 | 14 | $348.00 | $27.69 | 8.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 201 | 327 | $84,366 | $19,964 | 23.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 216 | 378 | $65,394 | $15,083 | 23.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 54 | 54 | $16,848 | $6,190 | 36.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 23 | 24 | $7,200 | $4,283 | 59.5% |
| G0181 | Physician supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of c | Office | 2020 | 17 | 29 | $7,308 | $2,475 | 33.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 35 | 37 | $2,520 | $2,214 | 87.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 16 | $5,568 | $1,684 | 30.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 20 | 35 | $3,675 | $1,215 | 33.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $1,793 | $679.93 | 37.9% |
About Dr. Patricia Buchanan, M.D
Dr. Patricia Buchanan, M.D is a Family Medicine healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487768859.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patricia Buchanan, M.D has received a total of $5,323 in payments from pharmaceutical and medical device companies, with $224.36 received in 2024. These payments were reported across 348 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,301).
As a Medicare-enrolled provider, Buchanan has provided services to 3,861 Medicare beneficiaries, totaling 4,848 services with total Medicare billing of $192,843. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Eugene, OR
- Active Since 08/19/2006
- Last Updated 09/23/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487768859
Products in Payments
- ELIQUIS (Drug) $571.80
- FARXIGA (Drug) $548.30
- CHANTIX (Drug) $475.14
- SYMBICORT (Drug) $265.15
- Livalo (Drug) $171.32
- ENTRESTO (Drug) $169.16
- Prolia (Biological) $166.74
- JANUVIA (Drug) $132.87
- VRAYLAR (Drug) $126.28
- EVENITY (Biological) $125.05
- BEXSERO (Biological) $121.74
- XARELTO (Drug) $118.74
- BEVESPI AEROSPHERE (Drug) $102.61
- Aimovig (Biological) $100.07
- TRULICITY (Drug) $96.96
- VIAGRA (Drug) $91.92
- TOVIAZ (Drug) $89.23
- Cologuard Collection Kit (Device) $69.07
- BYDUREON (Drug) $66.08
- QVAR (Drug) $63.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Eugene
Randy Reese, Md, MD
Family Medicine — Payments: $9,360
Hylke Snieder, M.d, M.D
Family Medicine — Payments: $4,297
David Kobliska, M.d, M.D
Family Medicine — Payments: $2,949
Doherty Gilchrist, Md, MD
Family Medicine — Payments: $1,786
Dr. Neema Reddy, Md, MD
Family Medicine — Payments: $1,592
Kathleen Cordes, Md, MD
Family Medicine — Payments: $1,452